Cigna-Express Scripts deal has already cost $201M

Amy Baxter | | Health Exec | Policy & Regulations
Money

The $67 billion mega-merger between Cigna and Express Scripts has already cost a staggering $201 million, Axios reported.

The deal, which has already been approved by shareholders and cleared by nearly half of the necessary regulators, is anticipated to close in the second half of 2018. Cigna cited the estimated actual transaction costs incurred by the deal in 2018 at $201 million in a filing with the Securities and Exchange Commission (SEC).

The transaction costs will likely be passed onto consumers, Axios reported. The deal brings together a major insurance provider and a large pharmacy benefits manager (PBM) at a time when the healthcare industry is seeing rapid consolidation. Another large PBM, CVS Health, is attempting to acquire insurance provider Aetna for $69 billion.

See the full report below:

The merger tab for Cigna and Express Scripts

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

A modest proposal to rally AI regulators around a simple game plan
FDA set to ban certain over-the-counter cold medications
FDA commissioner urges clinicians to join fight against medical misinformation
Looming fear of more IV shortages as Hurricane Rafael gains strength
Walgreens settles class-action fraud lawsuit for $100M
Boston Medical Center installs solar panels to pay patients’ electric bills

Around the web

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business
FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

AI in Healthcare
4 points crucial to the nimble regulation of GenAI

With generative AI coming into its own, AI regulators must avoid relying too much on principles of risk management—and not enough on those of uncertainty management.

Design by Adaptive Theme
Trimed Popup
Trimed Popup